ViroCarb is a science-driven biotech company founded and managed by an experienced team of scientists involved in world-leading research, with scientific management experience in discovering and developing small molecule therapeutics and accomplished executives in business development and commercialization.
Our Mission
To develop and commercialize our small molecule platform of broad spectrum anti-viral drugs to overcome the clinical challenge of current and future viral infections via a single mechanism, rather than the present piecemeal approach to individual viruses.
Copyright © 2024 ViroCarb Inc. - All Rights Reserved.